Elo Mutual Pension Insurance Co Boosts Stake in Cardinal Health, Inc. (NYSE:CAH)

Elo Mutual Pension Insurance Co grew its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 21.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 26,272 shares of the company's stock after buying an additional 4,718 shares during the quarter. Elo Mutual Pension Insurance Co's holdings in Cardinal Health were worth $3,107,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Cardinal Health by 5.6% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 433,810 shares of the company's stock worth $51,754,000 after acquiring an additional 23,140 shares during the last quarter. Korea Investment CORP grew its holdings in shares of Cardinal Health by 3.0% during the fourth quarter. Korea Investment CORP now owns 166,127 shares of the company's stock worth $19,648,000 after purchasing an additional 4,900 shares during the last quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund acquired a new position in shares of Cardinal Health in the fourth quarter valued at approximately $248,000. TrueMark Investments LLC raised its holdings in Cardinal Health by 14.1% in the 4th quarter. TrueMark Investments LLC now owns 3,583 shares of the company's stock valued at $424,000 after buying an additional 444 shares during the last quarter. Finally, TIAA Trust National Association boosted its position in Cardinal Health by 4.5% during the 4th quarter. TIAA Trust National Association now owns 2,183 shares of the company's stock worth $258,000 after buying an additional 94 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Price Performance

Shares of NYSE CAH traded up $1.70 during mid-day trading on Wednesday, reaching $138.83. 408,400 shares of the company's stock traded hands, compared to its average volume of 2,102,950. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $139.18. The stock has a market cap of $33.54 billion, a P/E ratio of 25.88, a PEG ratio of 1.49 and a beta of 0.66. The business has a 50-day simple moving average of $128.78 and a 200 day simple moving average of $121.20.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.46%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is presently 37.69%.

Analysts Set New Price Targets

Several research firms have recently issued reports on CAH. JPMorgan Chase & Co. raised their price target on shares of Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research note on Tuesday, February 4th. Evercore ISI upgraded Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price target on the stock in a research report on Tuesday, January 7th. Jefferies Financial Group upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and raised their price target for the stock from $140.00 to $150.00 in a report on Wednesday, February 5th. Argus set a $148.00 target price on shares of Cardinal Health in a report on Tuesday, February 4th. Finally, Citigroup lifted their price objective on Cardinal Health from $120.00 to $129.00 and gave the stock a "neutral" rating in a research report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company's stock. According to data from MarketBeat.com, Cardinal Health currently has a consensus rating of "Moderate Buy" and an average target price of $140.14.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.